학술논문

Improved Relapse-Free Survival in Patients With High Natural Killer Cell Doses in Grafts and During Early Immune Reconstitution After Allogeneic Stem Cell Transplantation.
Document Type
Article
Source
Frontiers in Immunology; 5/29/2020, Vol. 11, p1-15, 15p
Subject
KILLER cells
STEM cell transplantation
IMMUNOCOMPETENT cells
HEMATOPOIETIC stem cell transplantation
IMMUNE reconstitution inflammatory syndrome
STEM cells
Language
ISSN
16643224
Abstract
Copyright of Frontiers in Immunology is the property of Frontiers Media S.A. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)